Items tagged with Global TB response
US: Only 3 congressmen showed for a hearing on the No. 1 infectious killer in the world (post)
Dr. Tom Frieden, director of the Centers for Disease Control and Prevention, was there. Dr. Eric Goosby, the United Nations envoy for tuberculosis, was there. Dr. Ariel Pablo-Mendez, the U.S. Agency for International Development's assistant administrator for global health, was there.
Grand Challenges in TB Control: Third call for proposals (post)
Innovative solutions from India to improve TB detection, case notifications and treatment outcomes for adapting in developing countries in Africa and South Asia and scaling up in India
Invisible killer: The world’s most underestimated disease (post)
A bacterial infection is killing millions and growing stronger by the day. So why aren’t we rushing to stop it?
Aidspan publishes new issue of ‘Global Fund Observer’ (post)
Aidspan: Global Fund Observer
Global Fund outlines investment case to end epidemics (post)
TOKYO, 17 December 2015 - The Global Fund today presented its investment case for raising US$13 billion for its next three-year cycle of funding, outlining how partners in global health can contribute to ending HIV, tuberculosis and malaria as epidemics by 2030.
IJTLD January 2016 issue now online (post)
The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).
December 2015 issue of PHA now online (post)
Public Health Action is The Union's free access, online journal. The journal aims to promote the vision of The Union, Health solutions for the poor, by disseminating new knowledge on health systems and health services for vulnerable groups, with a priority on tuberculosis, lung health, non-communicable diseases and related public health issues.
Changing minds about tuberculosis (post)
The eradication of tuberculosis will require a fundamental overhaul of the way the disease is viewed, identified, and treated—this was the conclusion of two major recent publications about tackling the epidemic.
Looking for new funding models to address an ancient problem (post)
The global tuberculosis response has consistently suffered funding shortages, which contributed to the disease surpassing AIDS in 2014 as the world’s leading infectious killer. Now — in a bid to end the pandemic by 2035 — a new strategy is looking to alternative funding sources and new spending models that will help officials better take advantage of the available resources.
Prominent healthcare companies partner with USAID to combat drug-resistant tuberculosis (post)
WASHINGTON, D.C., January 7, 2016 - The U.S. Agency for International Development (USAID) announced two new partnerships today to add resources and cutting-edge technologies to fight drug-resistant tuberculosis (TB). Janssen, the pharmaceutical arm of Johnson & Johnson, announced a $15-20 million pledge as part of a new partnership with USAID to combat multidrug-resistant tuberculosis (MDR-TB). USAID will also partner with Cepheid, a maker of molecular systems and tests, to speed diagnosis of MDR-TB through increased access to rapid, accurate diagnostic tools.
Page 23 of 174 · Total posts: 0
←First 22 23 24 Last→